We also evaluated diagnostic accuracy of natriuretic peptides for heart failure, and procalcitonin (PCT) and C reactive peptide (CRP) for pneumonia.<h4>Results</h4>Of 751 participants, 44% (n=334) had breathlessness, and 316 underwent enhanced diagnostic screening. The gene discussed is CRP; the disease is susceptibility to pneumonia measurement.